| ACE2 | Angiotensin-converting enzyme 2 |
| APOBEC3 | Apolipoprotein B mRNA editing enzyme, catalytic subunit 3 |
| DRC | Democratic Republic of Congo |
| ds-cDNA | double stranded complementary dideoxynucleic acid |
| HC | Hybrid Capture |
| HIV | Human Immunodeficiency Virus |
| HPAIV | Highly Pathogenic Influenza A virus |
| IAV | Influenza A virus |
| LMIC | Low- and Middle-Income Countries |
| LOD | Limit of Detection |
| MERS-CoV | Middle East Respiratory Syndrome Coronavirus |
| ONT | Oxford Nanopore Technologies |
| OROV | Oropouche Virus |
| PCR | Polymerase Chain Reaction |
| PEG | Polyethylene Glycol |
| QC | Quality Control |
| rRNA | Ribosomal Ribonucleic acid |
| SARS-CoV-2 | Severe Acute Respiratory Syndrome Coronavirus 2 |
| SBV | Schmallenberg Virus |
| SISPA | Sequence-independent single primer amplification |
| SNP | Single nucleotide polymorphism |
| TMPRSS2 | Transmembrane Protease, Serine 2 |
| TNA | Total nucleic acid |
| vmNGS | Viral Metagenomic Next-Generation Sequencing |
| WGS | Whole genome sequencing |
| WHO | World Health Organisation |